Clinical Study

Serum Cholesterol Reduction Efficacy of Biscuits with Added Plant Stanol Ester

Table 5

Change in serum liver function test between control and stanol groups1.

ALTGGT
Baseline4 weeks% change2Baseline4 weeks% change2

Total subjects
 Control ( = 60)19.05 ± 15.9322.28 ± 13.58a27.9 ± 40.530.68 ± 28.0735.60 ± 36.03b12.1 ± 24.0
 Stanol ( = 59)18.47 ± 9.7822.54 ± 13.62a27.4 ± 57.340.32 ± 43.0547.20 ± 59.23b16.3 ± 48.2
Subjects who have normal baseline liver function test
 Control (n = 51)15.00 ± 6.7318.65 ± 9.66a27.4 ± 35.221.41 ± 11.1023.37 ± 12.81b9.3 ± 20.7
 Stanol ( = 45)15.86 ± 7.2520.23 ± 11.58a32.1 ± 63.924.23 ± 11.5829.11 ± 23.51b15.8 ± 44.9

Values are means ± SD. ALT: L-alanne aminotransferase (normal values of ALT: 5–40 U/L); GGT: gamma-glutamyltransferase (normal values of GGT for Male: 10–71 U/L, Female: 6–42 U/L).
2Percentage change is based on individual data, (4 weeks-baseline)/baseline × 100.
< 0.01, significant change over time comparing to baseline of ALT.
< 0.01, significant change over time comparing to baseline of GGT.